Pharmacokinetics, Tolerability and Safety of Favipiravir Compared to Ribavirin for the Treatment of Lassa Fever: A Randomized Controlled Open Label Phase II Clinical Trial
Latest Information Update: 10 Feb 2023
At a glance
- Drugs Favipiravir (Primary) ; Ribavirin
- Indications Lassa fever
- Focus Adverse reactions; Pharmacokinetics
- Acronyms SAFARI
- 07 Feb 2023 Status changed from active, no longer recruiting to completed.
- 18 Nov 2022 Planned primary completion date changed from 1 Sep 2022 to 1 Dec 2022.
- 18 Nov 2022 Status changed from recruiting to active, no longer recruiting.